Hemispherx 's new drug application for Ampligen was rejected by the FDA in December 2009 and the agency asked for another clinical study .
Ampligen permits sale and marketing .
Hemispherx 's new drug application for Ampligen , which permits sale and marketing , was rejected by the FDA in December 2009 and the agency asked for another clinical study .